avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tcf21
|
ENSMUSG00000045680.7 | transcription factor 21 |
Msc
|
ENSMUSG00000025930.5 | musculin |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Msc | mm10_v2_chr1_-_14755966_14755998 | 0.59 | 1.7e-04 | Click! |
Tcf21 | mm10_v2_chr10_-_22820126_22820150 | 0.38 | 2.2e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_-_137430517 | 4.85 |
ENSMUST00000102522.4
|
Cela3b
|
chymotrypsin-like elastase family, member 3B |
chr19_+_58759700 | 3.90 |
ENSMUST00000026081.3
|
Pnliprp2
|
pancreatic lipase-related protein 2 |
chr4_-_137409777 | 3.12 |
ENSMUST00000024200.6
|
Gm13011
|
predicted gene 13011 |
chr17_-_43502773 | 2.92 |
ENSMUST00000024707.8
ENSMUST00000117137.1 |
Mep1a
|
meprin 1 alpha |
chr1_+_135799402 | 2.82 |
ENSMUST00000152208.1
ENSMUST00000152075.1 ENSMUST00000154463.1 ENSMUST00000139986.1 |
Tnni1
|
troponin I, skeletal, slow 1 |
chr5_-_131538687 | 2.80 |
ENSMUST00000161374.1
|
Auts2
|
autism susceptibility candidate 2 |
chrX_+_101449078 | 2.71 |
ENSMUST00000033674.5
|
Itgb1bp2
|
integrin beta 1 binding protein 2 |
chr2_-_27072175 | 2.69 |
ENSMUST00000009358.2
|
Tmem8c
|
transmembrane protein 8C |
chr6_+_112459501 | 2.57 |
ENSMUST00000075477.6
|
Cav3
|
caveolin 3 |
chr1_+_135799833 | 2.54 |
ENSMUST00000148201.1
|
Tnni1
|
troponin I, skeletal, slow 1 |
chr11_+_104577281 | 2.38 |
ENSMUST00000106956.3
|
Myl4
|
myosin, light polypeptide 4 |
chr5_-_145805862 | 2.35 |
ENSMUST00000067479.5
|
Cyp3a44
|
cytochrome P450, family 3, subfamily a, polypeptide 44 |
chr12_+_109459843 | 2.32 |
ENSMUST00000173812.1
|
Dlk1
|
delta-like 1 homolog (Drosophila) |
chr4_-_87806276 | 2.30 |
ENSMUST00000148059.1
|
Mllt3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 |
chr4_-_87806296 | 2.22 |
ENSMUST00000126353.1
ENSMUST00000149357.1 |
Mllt3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 |
chr18_+_89197453 | 2.18 |
ENSMUST00000097496.2
|
Cd226
|
CD226 antigen |
chr7_+_143005046 | 2.16 |
ENSMUST00000009396.6
|
Tspan32
|
tetraspanin 32 |
chr19_+_52264323 | 2.12 |
ENSMUST00000039652.4
|
Ins1
|
insulin I |
chr16_-_16863975 | 2.12 |
ENSMUST00000100136.3
|
Igll1
|
immunoglobulin lambda-like polypeptide 1 |
chr13_-_100786402 | 2.08 |
ENSMUST00000174038.1
ENSMUST00000091295.7 ENSMUST00000072119.8 |
Ccnb1
|
cyclin B1 |
chr16_-_16863817 | 2.02 |
ENSMUST00000124890.1
|
Igll1
|
immunoglobulin lambda-like polypeptide 1 |
chr7_-_126447642 | 1.96 |
ENSMUST00000146973.1
|
Atp2a1
|
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 |
chr11_-_5803733 | 1.93 |
ENSMUST00000020768.3
|
Pgam2
|
phosphoglycerate mutase 2 |
chr11_+_115877497 | 1.87 |
ENSMUST00000144032.1
|
Myo15b
|
myosin XVB |
chr3_+_92288566 | 1.82 |
ENSMUST00000090872.4
|
Sprr2a3
|
small proline-rich protein 2A3 |
chr17_-_26199008 | 1.82 |
ENSMUST00000142410.1
ENSMUST00000120333.1 ENSMUST00000039113.7 |
Pdia2
|
protein disulfide isomerase associated 2 |
chr14_-_31577318 | 1.81 |
ENSMUST00000112027.2
|
Colq
|
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
chr7_+_25152456 | 1.79 |
ENSMUST00000098678.1
|
D930028M14Rik
|
RIKEN cDNA D930028M14 gene |
chr5_-_100159261 | 1.79 |
ENSMUST00000139520.1
|
Tmem150c
|
transmembrane protein 150C |
chr14_-_20269162 | 1.77 |
ENSMUST00000024155.7
|
Kcnk16
|
potassium channel, subfamily K, member 16 |
chr11_-_102365111 | 1.76 |
ENSMUST00000006749.9
|
Slc4a1
|
solute carrier family 4 (anion exchanger), member 1 |
chr11_+_104576965 | 1.72 |
ENSMUST00000106957.1
|
Myl4
|
myosin, light polypeptide 4 |
chr5_-_145469723 | 1.72 |
ENSMUST00000031633.4
|
Cyp3a16
|
cytochrome P450, family 3, subfamily a, polypeptide 16 |
chr3_-_75270073 | 1.69 |
ENSMUST00000039047.4
|
Serpini2
|
serine (or cysteine) peptidase inhibitor, clade I, member 2 |
chr17_-_35085609 | 1.68 |
ENSMUST00000038507.6
|
Ly6g6f
|
lymphocyte antigen 6 complex, locus G6F |
chr8_+_94172618 | 1.66 |
ENSMUST00000034214.6
|
Mt2
|
metallothionein 2 |
chr11_-_107716517 | 1.54 |
ENSMUST00000021065.5
|
Cacng1
|
calcium channel, voltage-dependent, gamma subunit 1 |
chr16_+_45610380 | 1.54 |
ENSMUST00000161347.2
ENSMUST00000023339.4 |
Gcsam
|
germinal center associated, signaling and motility |
chr7_+_45216671 | 1.51 |
ENSMUST00000134420.1
|
Tead2
|
TEA domain family member 2 |
chr4_-_149454971 | 1.47 |
ENSMUST00000030848.2
|
Rbp7
|
retinol binding protein 7, cellular |
chr9_-_114781986 | 1.46 |
ENSMUST00000035009.8
ENSMUST00000084867.7 |
Cmtm7
|
CKLF-like MARVEL transmembrane domain containing 7 |
chr15_+_75156693 | 1.45 |
ENSMUST00000023246.3
|
Ly6g
|
lymphocyte antigen 6 complex, locus G |
chr3_-_152166230 | 1.44 |
ENSMUST00000046614.9
|
Gipc2
|
GIPC PDZ domain containing family, member 2 |
chr8_+_21134610 | 1.42 |
ENSMUST00000098898.4
|
Gm15284
|
predicted gene 15284 |
chr5_+_31116702 | 1.42 |
ENSMUST00000013771.8
|
Trim54
|
tripartite motif-containing 54 |
chr5_+_31116722 | 1.39 |
ENSMUST00000114637.1
|
Trim54
|
tripartite motif-containing 54 |
chr12_-_28582515 | 1.36 |
ENSMUST00000110917.1
ENSMUST00000020965.7 |
Allc
|
allantoicase |
chr16_+_96200470 | 1.33 |
ENSMUST00000048770.8
|
Sh3bgr
|
SH3-binding domain glutamic acid-rich protein |
chr17_+_36869567 | 1.32 |
ENSMUST00000060524.9
|
Trim10
|
tripartite motif-containing 10 |
chr18_+_50051702 | 1.32 |
ENSMUST00000134348.1
ENSMUST00000153873.2 |
Tnfaip8
|
tumor necrosis factor, alpha-induced protein 8 |
chr9_+_121777607 | 1.27 |
ENSMUST00000098272.2
|
Klhl40
|
kelch-like 40 |
chr4_+_155962292 | 1.22 |
ENSMUST00000024338.4
|
Fam132a
|
family with sequence similarity 132, member A |
chrX_-_102252154 | 1.21 |
ENSMUST00000050551.3
|
Cited1
|
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 |
chr3_+_51661167 | 1.20 |
ENSMUST00000099106.3
|
Mgst2
|
microsomal glutathione S-transferase 2 |
chrX_-_142306170 | 1.20 |
ENSMUST00000134825.2
|
Kcne1l
|
potassium voltage-gated channel, Isk-related family, member 1-like, pseudogene |
chr3_+_92316705 | 1.19 |
ENSMUST00000061038.2
|
Sprr2b
|
small proline-rich protein 2B |
chr13_+_95696851 | 1.19 |
ENSMUST00000022182.4
|
F2rl2
|
coagulation factor II (thrombin) receptor-like 2 |
chr17_-_48432723 | 1.16 |
ENSMUST00000046549.3
|
Apobec2
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2 |
chr2_+_84734050 | 1.14 |
ENSMUST00000090729.2
|
Ypel4
|
yippee-like 4 (Drosophila) |
chr11_+_67200052 | 1.12 |
ENSMUST00000124516.1
ENSMUST00000018637.8 |
Myh1
|
myosin, heavy polypeptide 1, skeletal muscle, adult |
chr17_+_55952623 | 1.12 |
ENSMUST00000003274.6
|
Ebi3
|
Epstein-Barr virus induced gene 3 |
chr13_+_46418266 | 1.11 |
ENSMUST00000037923.3
|
Rbm24
|
RNA binding motif protein 24 |
chr9_-_39603635 | 1.09 |
ENSMUST00000119722.1
|
AW551984
|
expressed sequence AW551984 |
chr1_-_166127876 | 1.09 |
ENSMUST00000085992.2
|
Dusp27
|
dual specificity phosphatase 27 (putative) |
chr5_-_145720124 | 1.08 |
ENSMUST00000094111.4
|
Cyp3a41a
|
cytochrome P450, family 3, subfamily a, polypeptide 41A |
chr18_+_62180119 | 1.07 |
ENSMUST00000067743.1
|
Gm9949
|
predicted gene 9949 |
chr6_-_145210791 | 1.07 |
ENSMUST00000111728.1
ENSMUST00000060797.7 |
Casc1
|
cancer susceptibility candidate 1 |
chr5_-_73191848 | 1.07 |
ENSMUST00000176910.1
|
Fryl
|
furry homolog-like (Drosophila) |
chr19_-_15924560 | 1.07 |
ENSMUST00000162053.1
|
Psat1
|
phosphoserine aminotransferase 1 |
chr8_+_94377911 | 1.03 |
ENSMUST00000159142.1
|
Gm15889
|
predicted gene 15889 |
chr9_-_39604124 | 1.03 |
ENSMUST00000042485.4
ENSMUST00000141370.1 |
AW551984
|
expressed sequence AW551984 |
chr7_-_81566939 | 1.03 |
ENSMUST00000042318.5
|
Fsd2
|
fibronectin type III and SPRY domain containing 2 |
chrX_-_106485214 | 1.02 |
ENSMUST00000039447.7
|
Fndc3c1
|
fibronectin type III domain containing 3C1 |
chr10_+_82985473 | 1.01 |
ENSMUST00000040110.7
|
Chst11
|
carbohydrate sulfotransferase 11 |
chr6_+_29398920 | 1.00 |
ENSMUST00000181464.1
ENSMUST00000180829.1 |
Ccdc136
|
coiled-coil domain containing 136 |
chr14_-_20656488 | 0.99 |
ENSMUST00000090469.6
|
Myoz1
|
myozenin 1 |
chr2_+_157560078 | 0.99 |
ENSMUST00000153739.2
ENSMUST00000173595.1 ENSMUST00000109526.1 ENSMUST00000173839.1 ENSMUST00000173041.1 ENSMUST00000173793.1 ENSMUST00000172487.1 ENSMUST00000088484.5 |
Nnat
|
neuronatin |
chr7_-_126704522 | 0.98 |
ENSMUST00000135087.1
|
Coro1a
|
coronin, actin binding protein 1A |
chr2_-_121037048 | 0.98 |
ENSMUST00000102490.3
|
Epb4.2
|
erythrocyte protein band 4.2 |
chr5_-_145584723 | 0.97 |
ENSMUST00000075837.6
|
Cyp3a41b
|
cytochrome P450, family 3, subfamily a, polypeptide 41B |
chr5_+_115466234 | 0.93 |
ENSMUST00000145785.1
ENSMUST00000031495.4 ENSMUST00000112071.1 ENSMUST00000125568.1 |
Pla2g1b
|
phospholipase A2, group IB, pancreas |
chr7_+_43950614 | 0.93 |
ENSMUST00000072204.4
|
Klk1b8
|
kallikrein 1-related peptidase b8 |
chr17_-_87797994 | 0.93 |
ENSMUST00000055221.7
|
Kcnk12
|
potassium channel, subfamily K, member 12 |
chr8_-_122432924 | 0.92 |
ENSMUST00000017604.8
|
Cyba
|
cytochrome b-245, alpha polypeptide |
chr3_-_20242173 | 0.90 |
ENSMUST00000001921.1
|
Cpa3
|
carboxypeptidase A3, mast cell |
chr2_-_76982455 | 0.90 |
ENSMUST00000011934.5
ENSMUST00000099981.2 ENSMUST00000099980.3 ENSMUST00000111882.2 ENSMUST00000140091.1 |
Ttn
|
titin |
chr11_+_61126747 | 0.88 |
ENSMUST00000010286.1
ENSMUST00000146033.1 ENSMUST00000139422.1 |
Tnfrsf13b
|
tumor necrosis factor receptor superfamily, member 13b |
chr11_-_75796048 | 0.88 |
ENSMUST00000021209.7
|
Doc2b
|
double C2, beta |
chr2_-_105399286 | 0.86 |
ENSMUST00000006128.6
|
Rcn1
|
reticulocalbin 1 |
chr7_-_67803489 | 0.85 |
ENSMUST00000181235.1
|
4833412C05Rik
|
RIKEN cDNA 4833412C05 gene |
chr4_+_119814495 | 0.85 |
ENSMUST00000106307.2
|
Hivep3
|
human immunodeficiency virus type I enhancer binding protein 3 |
chr7_+_127211608 | 0.84 |
ENSMUST00000032910.6
|
Mylpf
|
myosin light chain, phosphorylatable, fast skeletal muscle |
chr7_-_126704736 | 0.83 |
ENSMUST00000131415.1
|
Coro1a
|
coronin, actin binding protein 1A |
chr5_+_123749696 | 0.82 |
ENSMUST00000031366.7
|
Kntc1
|
kinetochore associated 1 |
chr1_+_75375271 | 0.82 |
ENSMUST00000087122.5
|
Speg
|
SPEG complex locus |
chr7_+_67952817 | 0.81 |
ENSMUST00000005671.8
|
Igf1r
|
insulin-like growth factor I receptor |
chr6_+_107529717 | 0.81 |
ENSMUST00000049285.8
|
Lrrn1
|
leucine rich repeat protein 1, neuronal |
chr2_+_153492790 | 0.80 |
ENSMUST00000109783.1
|
4930404H24Rik
|
RIKEN cDNA 4930404H24 gene |
chr14_-_56571830 | 0.80 |
ENSMUST00000065302.7
|
Cenpj
|
centromere protein J |
chr7_-_126704816 | 0.80 |
ENSMUST00000032949.7
|
Coro1a
|
coronin, actin binding protein 1A |
chr10_-_88356990 | 0.79 |
ENSMUST00000020249.1
|
Dram1
|
DNA-damage regulated autophagy modulator 1 |
chr7_-_127993831 | 0.79 |
ENSMUST00000033056.3
|
Pycard
|
PYD and CARD domain containing |
chr5_-_135251209 | 0.78 |
ENSMUST00000062572.2
|
Fzd9
|
frizzled homolog 9 (Drosophila) |
chr1_+_88227005 | 0.77 |
ENSMUST00000061013.6
ENSMUST00000113130.1 |
Mroh2a
|
maestro heat-like repeat family member 2A |
chr9_+_119063429 | 0.77 |
ENSMUST00000141185.1
ENSMUST00000126251.1 ENSMUST00000136561.1 |
Vill
|
villin-like |
chr7_-_4514368 | 0.77 |
ENSMUST00000166161.1
|
Tnnt1
|
troponin T1, skeletal, slow |
chr7_-_4514558 | 0.75 |
ENSMUST00000163538.1
|
Tnnt1
|
troponin T1, skeletal, slow |
chr5_+_91517615 | 0.75 |
ENSMUST00000040576.9
|
Parm1
|
prostate androgen-regulated mucin-like protein 1 |
chr4_+_133480126 | 0.74 |
ENSMUST00000051676.6
|
Fam46b
|
family with sequence similarity 46, member B |
chr5_-_138171248 | 0.74 |
ENSMUST00000153867.1
|
Mcm7
|
minichromosome maintenance deficient 7 (S. cerevisiae) |
chr13_-_74062262 | 0.73 |
ENSMUST00000036456.6
|
Cep72
|
centrosomal protein 72 |
chr6_+_145145473 | 0.73 |
ENSMUST00000156849.1
ENSMUST00000132948.1 |
Lrmp
|
lymphoid-restricted membrane protein |
chr8_+_45885479 | 0.72 |
ENSMUST00000034053.5
|
Pdlim3
|
PDZ and LIM domain 3 |
chr16_+_93832121 | 0.71 |
ENSMUST00000044068.6
|
Morc3
|
microrchidia 3 |
chr3_-_68870266 | 0.71 |
ENSMUST00000166328.1
|
Gm17641
|
predicted gene, 17641 |
chr2_+_130274437 | 0.70 |
ENSMUST00000141872.1
|
Nop56
|
NOP56 ribonucleoprotein |
chr7_+_97842917 | 0.69 |
ENSMUST00000033040.5
|
Pak1
|
p21 protein (Cdc42/Rac)-activated kinase 1 |
chrX_-_104671048 | 0.69 |
ENSMUST00000042070.5
|
Zdhhc15
|
zinc finger, DHHC domain containing 15 |
chr11_+_115899943 | 0.69 |
ENSMUST00000152171.1
|
Smim5
|
small integral membrane protein 5 |
chr7_+_110772604 | 0.69 |
ENSMUST00000005829.6
|
Ampd3
|
adenosine monophosphate deaminase 3 |
chr15_+_80623499 | 0.69 |
ENSMUST00000043149.7
|
Grap2
|
GRB2-related adaptor protein 2 |
chr11_+_115900125 | 0.68 |
ENSMUST00000142089.1
ENSMUST00000131566.1 |
Smim5
|
small integral membrane protein 5 |
chr2_-_170427828 | 0.68 |
ENSMUST00000013667.2
ENSMUST00000109152.2 ENSMUST00000068137.4 |
Bcas1
|
breast carcinoma amplified sequence 1 |
chr6_+_113392417 | 0.66 |
ENSMUST00000032414.4
ENSMUST00000038889.5 |
Ttll3
|
tubulin tyrosine ligase-like family, member 3 |
chr4_+_33062999 | 0.66 |
ENSMUST00000108162.1
ENSMUST00000024035.2 |
Gabrr2
|
gamma-aminobutyric acid (GABA) C receptor, subunit rho 2 |
chr1_+_136052771 | 0.66 |
ENSMUST00000112068.3
|
Cacna1s
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
chr1_-_135375233 | 0.66 |
ENSMUST00000041240.3
|
Shisa4
|
shisa homolog 4 (Xenopus laevis) |
chrX_+_56454871 | 0.63 |
ENSMUST00000039374.2
ENSMUST00000101553.2 |
Ddx26b
|
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 26B |
chr8_+_121544378 | 0.62 |
ENSMUST00000181133.1
ENSMUST00000181679.1 |
1700030M09Rik
|
RIKEN cDNA 1700030M09 gene |
chr1_+_136052750 | 0.62 |
ENSMUST00000160641.1
|
Cacna1s
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
chr5_-_137212389 | 0.61 |
ENSMUST00000179412.1
|
A630081J09Rik
|
RIKEN cDNA A630081J09 gene |
chr2_+_174760619 | 0.61 |
ENSMUST00000029030.2
|
Edn3
|
endothelin 3 |
chr3_-_100489324 | 0.61 |
ENSMUST00000061455.8
|
Fam46c
|
family with sequence similarity 46, member C |
chr7_-_4514609 | 0.60 |
ENSMUST00000166959.1
|
Tnnt1
|
troponin T1, skeletal, slow |
chr1_+_136052804 | 0.60 |
ENSMUST00000112064.1
|
Cacna1s
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
chr5_+_12383156 | 0.59 |
ENSMUST00000030868.6
|
Sema3d
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D |
chr15_+_85510812 | 0.59 |
ENSMUST00000079690.2
|
Gm4825
|
predicted pseudogene 4825 |
chr5_-_138171216 | 0.59 |
ENSMUST00000147920.1
|
Mcm7
|
minichromosome maintenance deficient 7 (S. cerevisiae) |
chr9_-_40346290 | 0.58 |
ENSMUST00000121357.1
|
Gramd1b
|
GRAM domain containing 1B |
chr3_+_109573907 | 0.58 |
ENSMUST00000106576.2
|
Vav3
|
vav 3 oncogene |
chr3_-_129831374 | 0.56 |
ENSMUST00000029643.8
|
Gar1
|
GAR1 ribonucleoprotein homolog (yeast) |
chr8_+_94977101 | 0.56 |
ENSMUST00000179619.1
|
Gpr56
|
G protein-coupled receptor 56 |
chr7_+_142471838 | 0.56 |
ENSMUST00000038946.2
|
Lsp1
|
lymphocyte specific 1 |
chr2_-_162661075 | 0.55 |
ENSMUST00000109442.1
ENSMUST00000109445.2 ENSMUST00000109443.1 ENSMUST00000109441.1 |
Ptprt
|
protein tyrosine phosphatase, receptor type, T |
chr1_+_130731963 | 0.55 |
ENSMUST00000039323.6
|
AA986860
|
expressed sequence AA986860 |
chr6_-_54566484 | 0.55 |
ENSMUST00000019268.4
|
Scrn1
|
secernin 1 |
chr5_+_136057267 | 0.53 |
ENSMUST00000006303.4
ENSMUST00000156530.1 |
Upk3bl
|
uroplakin 3B-like |
chr19_+_11516473 | 0.53 |
ENSMUST00000163078.1
|
Ms4a6b
|
membrane-spanning 4-domains, subfamily A, member 6B |
chr12_-_86079019 | 0.53 |
ENSMUST00000003687.6
|
Tgfb3
|
transforming growth factor, beta 3 |
chr5_-_31202215 | 0.53 |
ENSMUST00000176245.1
ENSMUST00000177310.1 ENSMUST00000114590.1 |
Zfp513
|
zinc finger protein 513 |
chr6_-_52158292 | 0.52 |
ENSMUST00000000964.5
ENSMUST00000120363.1 |
Hoxa1
|
homeobox A1 |
chr7_+_122289297 | 0.52 |
ENSMUST00000064989.5
ENSMUST00000064921.4 |
Prkcb
|
protein kinase C, beta |
chr12_+_36314160 | 0.52 |
ENSMUST00000041407.5
|
Sostdc1
|
sclerostin domain containing 1 |
chr9_+_65361049 | 0.52 |
ENSMUST00000147185.1
|
Gm514
|
predicted gene 514 |
chr4_+_48045144 | 0.52 |
ENSMUST00000030025.3
|
Nr4a3
|
nuclear receptor subfamily 4, group A, member 3 |
chr17_+_32621319 | 0.52 |
ENSMUST00000077639.5
|
Gm9705
|
predicted gene 9705 |
chr6_-_3494587 | 0.52 |
ENSMUST00000049985.8
|
Hepacam2
|
HEPACAM family member 2 |
chr1_-_172895048 | 0.51 |
ENSMUST00000027824.5
|
Apcs
|
serum amyloid P-component |
chr7_+_142472080 | 0.51 |
ENSMUST00000105966.1
|
Lsp1
|
lymphocyte specific 1 |
chr14_+_32856756 | 0.51 |
ENSMUST00000053175.5
ENSMUST00000100721.2 |
Vstm4
|
V-set and transmembrane domain containing 4 |
chr3_+_96557950 | 0.51 |
ENSMUST00000074519.6
ENSMUST00000049093.7 |
Txnip
|
thioredoxin interacting protein |
chr9_-_67043832 | 0.51 |
ENSMUST00000113686.1
|
Tpm1
|
tropomyosin 1, alpha |
chrX_+_100730178 | 0.51 |
ENSMUST00000113744.1
|
Gdpd2
|
glycerophosphodiester phosphodiesterase domain containing 2 |
chr4_+_86930691 | 0.50 |
ENSMUST00000164590.1
|
Acer2
|
alkaline ceramidase 2 |
chr3_+_96181151 | 0.50 |
ENSMUST00000035371.8
|
Sv2a
|
synaptic vesicle glycoprotein 2 a |
chr1_+_87205799 | 0.49 |
ENSMUST00000027470.7
|
Chrng
|
cholinergic receptor, nicotinic, gamma polypeptide |
chr1_+_135836380 | 0.49 |
ENSMUST00000178204.1
|
Tnnt2
|
troponin T2, cardiac |
chr2_-_163087770 | 0.49 |
ENSMUST00000094653.4
|
Gtsf1l
|
gametocyte specific factor 1-like |
chr3_-_126998408 | 0.49 |
ENSMUST00000182764.1
ENSMUST00000044443.8 |
Ank2
|
ankyrin 2, brain |
chr17_-_7385305 | 0.49 |
ENSMUST00000070059.3
|
Gm9992
|
predicted gene 9992 |
chr6_-_29212240 | 0.49 |
ENSMUST00000160878.1
ENSMUST00000078155.5 |
Impdh1
|
inosine 5'-phosphate dehydrogenase 1 |
chr10_+_79854618 | 0.49 |
ENSMUST00000165704.1
|
Ptbp1
|
polypyrimidine tract binding protein 1 |
chr5_-_73647713 | 0.47 |
ENSMUST00000081170.7
|
Sgcb
|
sarcoglycan, beta (dystrophin-associated glycoprotein) |
chr2_+_152911311 | 0.47 |
ENSMUST00000028970.7
|
Mylk2
|
myosin, light polypeptide kinase 2, skeletal muscle |
chr11_+_67321778 | 0.47 |
ENSMUST00000180845.1
|
Myh13
|
myosin, heavy polypeptide 13, skeletal muscle |
chr9_-_96437434 | 0.46 |
ENSMUST00000070500.2
|
BC043934
|
cDNA sequence BC043934 |
chr6_+_29694204 | 0.46 |
ENSMUST00000046750.7
ENSMUST00000115250.3 |
Tspan33
|
tetraspanin 33 |
chr15_-_100669496 | 0.46 |
ENSMUST00000182814.1
ENSMUST00000182068.1 |
Bin2
|
bridging integrator 2 |
chr3_+_40800778 | 0.46 |
ENSMUST00000169566.1
|
Plk4
|
polo-like kinase 4 |
chr5_+_134676490 | 0.46 |
ENSMUST00000100641.2
|
Gm10369
|
predicted gene 10369 |
chr17_-_33951438 | 0.46 |
ENSMUST00000087543.2
|
B3galt4
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 |
chr15_+_78926720 | 0.46 |
ENSMUST00000089377.5
|
Lgals1
|
lectin, galactose binding, soluble 1 |
chr4_-_133967893 | 0.45 |
ENSMUST00000100472.3
ENSMUST00000136327.1 |
Hmgn2
|
high mobility group nucleosomal binding domain 2 |
chr2_-_5862923 | 0.45 |
ENSMUST00000071016.2
|
Gm13199
|
predicted gene 13199 |
chr14_-_8666236 | 0.45 |
ENSMUST00000102996.3
|
4930452B06Rik
|
RIKEN cDNA 4930452B06 gene |
chr14_+_33923582 | 0.45 |
ENSMUST00000168727.1
|
Gdf10
|
growth differentiation factor 10 |
chr3_+_107036156 | 0.45 |
ENSMUST00000052718.3
|
Kcna3
|
potassium voltage-gated channel, shaker-related subfamily, member 3 |
chr5_+_137641334 | 0.44 |
ENSMUST00000177466.1
ENSMUST00000166099.2 |
Sap25
|
sin3 associated polypeptide |
chr8_+_92901387 | 0.44 |
ENSMUST00000104947.2
|
Capns2
|
calpain, small subunit 2 |
chr14_+_55853997 | 0.44 |
ENSMUST00000100529.3
|
Nynrin
|
NYN domain and retroviral integrase containing |
chr5_-_34637107 | 0.44 |
ENSMUST00000124668.1
ENSMUST00000001109.4 ENSMUST00000155577.1 ENSMUST00000114329.1 |
Mfsd10
|
major facilitator superfamily domain containing 10 |
chr11_+_113619318 | 0.44 |
ENSMUST00000146390.2
ENSMUST00000106630.1 |
Sstr2
|
somatostatin receptor 2 |
chr7_-_45239108 | 0.43 |
ENSMUST00000033063.6
|
Cd37
|
CD37 antigen |
chr7_-_29213957 | 0.43 |
ENSMUST00000169143.1
ENSMUST00000047846.6 |
Catsperg1
|
catsper channel auxiliary subunit gamma 1 |
chr15_-_100669512 | 0.43 |
ENSMUST00000182574.1
ENSMUST00000182775.1 |
Bin2
|
bridging integrator 2 |
chr7_-_25615874 | 0.43 |
ENSMUST00000098663.1
|
Gm7092
|
predicted gene 7092 |
chr15_-_100669535 | 0.43 |
ENSMUST00000183211.1
|
Bin2
|
bridging integrator 2 |
chr16_-_32810477 | 0.43 |
ENSMUST00000179384.2
|
Gm933
|
predicted gene 933 |
chr7_-_25132473 | 0.43 |
ENSMUST00000108418.4
ENSMUST00000108415.3 ENSMUST00000098679.3 ENSMUST00000175774.2 ENSMUST00000108417.3 ENSMUST00000108416.3 ENSMUST00000108414.1 ENSMUST00000108413.1 ENSMUST00000176408.1 |
Pou2f2
|
POU domain, class 2, transcription factor 2 |
chr6_+_112273758 | 0.42 |
ENSMUST00000032376.5
|
Lmcd1
|
LIM and cysteine-rich domains 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.8 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.7 | 1.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.7 | 2.2 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
0.7 | 2.1 | GO:0031662 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
0.7 | 2.0 | GO:0051659 | maintenance of mitochondrion location(GO:0051659) relaxation of skeletal muscle(GO:0090076) |
0.5 | 0.5 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.4 | 2.6 | GO:0032796 | uropod organization(GO:0032796) |
0.4 | 3.5 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.4 | 2.1 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.4 | 1.9 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.4 | 1.5 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.4 | 5.2 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.3 | 1.3 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.3 | 0.9 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.3 | 0.9 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.3 | 1.8 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.3 | 4.7 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.3 | 0.8 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.3 | 0.8 | GO:1990523 | bone regeneration(GO:1990523) |
0.3 | 2.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.2 | 0.5 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.2 | 0.2 | GO:1904057 | negative regulation of sensory perception of pain(GO:1904057) |
0.2 | 1.2 | GO:0071105 | response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) |
0.2 | 0.7 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.2 | 1.7 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.2 | 1.4 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.2 | 3.7 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.2 | 1.9 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.2 | 0.8 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.2 | 1.0 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.2 | 0.5 | GO:0071846 | actin filament debranching(GO:0071846) |
0.2 | 0.5 | GO:0003032 | detection of oxygen(GO:0003032) |
0.2 | 0.5 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.2 | 1.7 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 0.5 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.2 | 0.5 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
0.2 | 0.5 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.2 | 0.5 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.2 | 0.8 | GO:0061511 | centriole elongation(GO:0061511) |
0.2 | 1.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 0.3 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.2 | 2.1 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.2 | 0.2 | GO:0099548 | trans-synaptic signaling by nitric oxide(GO:0099548) |
0.1 | 0.9 | GO:0014826 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) vein smooth muscle contraction(GO:0014826) |
0.1 | 0.4 | GO:0009397 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.1 | 0.4 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) detection of bacterial lipopeptide(GO:0070340) |
0.1 | 0.7 | GO:0021764 | amygdala development(GO:0021764) negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.7 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 1.2 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
0.1 | 0.4 | GO:0036292 | DNA rewinding(GO:0036292) |
0.1 | 0.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.3 | GO:0035744 | T-helper 1 cell cytokine production(GO:0035744) regulation of T-helper 1 cell cytokine production(GO:2000554) positive regulation of T-helper 1 cell cytokine production(GO:2000556) |
0.1 | 1.4 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.5 | GO:0021664 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.1 | 4.4 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 0.6 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.1 | 1.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.3 | GO:2000412 | lymphocyte migration into lymphoid organs(GO:0097021) positive regulation of thymocyte migration(GO:2000412) regulation of immunological synapse formation(GO:2000520) regulation of dendritic cell dendrite assembly(GO:2000547) |
0.1 | 0.3 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.1 | 0.8 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.4 | GO:0090095 | canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.1 | 1.0 | GO:0048703 | chondroitin sulfate biosynthetic process(GO:0030206) embryonic viscerocranium morphogenesis(GO:0048703) |
0.1 | 4.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.1 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.1 | 0.5 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
0.1 | 0.4 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 0.3 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.1 | 0.3 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 0.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 2.3 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 0.3 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.1 | 0.7 | GO:0032264 | IMP salvage(GO:0032264) |
0.1 | 0.2 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.1 | 1.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.9 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.1 | 1.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.3 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 0.2 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.1 | 1.5 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.2 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.3 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.1 | 1.6 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.1 | 0.3 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 | 1.2 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.4 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
0.1 | 2.8 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 0.2 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.1 | 0.8 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.5 | GO:0036371 | T-tubule organization(GO:0033292) protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
0.1 | 0.4 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.3 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.2 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
0.1 | 0.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.3 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.1 | 0.4 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.0 | 0.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.2 | GO:0042117 | monocyte activation(GO:0042117) |
0.0 | 0.6 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.0 | 1.0 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 2.3 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.1 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.0 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.2 | GO:0090346 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.0 | 1.4 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 1.3 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 1.4 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.0 | 0.9 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.0 | 0.1 | GO:0003127 | detection of nodal flow(GO:0003127) detection of endogenous stimulus(GO:0009726) |
0.0 | 0.9 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.3 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.0 | 0.7 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.0 | 0.1 | GO:2000843 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) |
0.0 | 0.2 | GO:0032439 | endosome localization(GO:0032439) |
0.0 | 0.8 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.0 | 0.2 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.0 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.2 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.0 | 0.4 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) regulation of membrane repolarization during action potential(GO:0098903) |
0.0 | 0.2 | GO:1904382 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.0 | 0.5 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.5 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.0 | 0.7 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.2 | GO:1905169 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
0.0 | 0.1 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.0 | 0.2 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.0 | 0.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.0 | 0.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.0 | GO:1902730 | positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.0 | 0.1 | GO:0061314 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) Notch signaling involved in heart development(GO:0061314) |
0.0 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.2 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.0 | 0.2 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.0 | 0.4 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.0 | 0.1 | GO:0050904 | diapedesis(GO:0050904) |
0.0 | 0.1 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.0 | 0.8 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.3 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.2 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.0 | 0.2 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.0 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.9 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.3 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.0 | 0.3 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.0 | 0.1 | GO:0021852 | pyramidal neuron migration(GO:0021852) |
0.0 | 0.7 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 1.3 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.0 | 0.5 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.3 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.1 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.0 | 0.3 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.0 | 0.8 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.2 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.0 | GO:0031179 | peptide modification(GO:0031179) |
0.0 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.1 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.0 | 0.6 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.0 | 0.2 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.3 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.4 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.0 | 0.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.0 | 0.2 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.0 | 0.4 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.0 | 0.7 | GO:0051693 | actin filament capping(GO:0051693) |
0.0 | 0.9 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.0 | 0.2 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.7 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.1 | GO:0060083 | detection of temperature stimulus involved in thermoception(GO:0050960) smooth muscle contraction involved in micturition(GO:0060083) positive regulation of gastric acid secretion(GO:0060454) response to capsazepine(GO:1901594) |
0.0 | 0.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.0 | 0.5 | GO:0060004 | reflex(GO:0060004) |
0.0 | 0.1 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.0 | 0.3 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0014857 | skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) skeletal muscle cell proliferation(GO:0014856) regulation of skeletal muscle cell proliferation(GO:0014857) |
0.0 | 0.1 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.0 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.4 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.0 | GO:2000409 | regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
0.0 | 0.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.2 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.2 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.1 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.0 | 0.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.0 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.0 | 0.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.0 | 0.8 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 0.0 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.0 | 0.4 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.2 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.5 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.8 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.0 | 0.1 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.0 | 0.6 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.1 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 | 0.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.2 | GO:0003016 | respiratory system process(GO:0003016) |
0.0 | 0.1 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 2.2 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
0.5 | 2.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.5 | 1.5 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.4 | 8.0 | GO:0005861 | troponin complex(GO:0005861) |
0.3 | 2.0 | GO:0031673 | H zone(GO:0031673) |
0.3 | 0.8 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 3.6 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 4.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.2 | 0.8 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 3.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 8.2 | GO:0031672 | A band(GO:0031672) |
0.1 | 1.7 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.6 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.1 | 2.4 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 1.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.3 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
0.1 | 4.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.8 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.3 | GO:0008623 | CHRAC(GO:0008623) |
0.1 | 3.0 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 4.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.5 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.4 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.2 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.2 | GO:1990696 | USH2 complex(GO:1990696) |
0.1 | 0.2 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.1 | GO:0005940 | septin ring(GO:0005940) |
0.0 | 6.3 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.1 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.2 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.0 | 0.2 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.0 | 0.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.2 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 0.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.0 | 2.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 1.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.0 | 0.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 1.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.2 | GO:0031674 | I band(GO:0031674) |
0.0 | 0.1 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 0.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 1.7 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.3 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 2.5 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 4.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.4 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.0 | 0.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 6.1 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.6 | 1.9 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.5 | 2.1 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.5 | 1.5 | GO:0045159 | myosin II binding(GO:0045159) |
0.3 | 1.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 1.2 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.3 | 1.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.3 | 0.8 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
0.3 | 3.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 2.6 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 0.5 | GO:0048030 | disaccharide binding(GO:0048030) |
0.2 | 0.9 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 2.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 2.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 1.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 0.5 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.2 | 4.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 1.8 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 2.0 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.4 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.1 | 0.4 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.7 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.5 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 5.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 2.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 1.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.5 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.1 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.1 | 0.5 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.1 | 1.2 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 0.5 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.1 | 0.3 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.3 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.1 | 1.5 | GO:0016918 | retinal binding(GO:0016918) retinol binding(GO:0019841) |
0.1 | 1.7 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.8 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.7 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 0.9 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 1.8 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.3 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.1 | 0.5 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 1.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.6 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 0.7 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.2 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
0.1 | 1.5 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 0.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.3 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.1 | 2.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.5 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.2 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) |
0.1 | 0.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.5 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.5 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.2 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.2 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.0 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 1.7 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 1.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 1.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 2.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 2.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.0 | 0.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.2 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.0 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 3.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 3.7 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.4 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 0.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.0 | 0.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 0.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.1 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.0 | 0.2 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.0 | 0.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 1.2 | GO:0004601 | peroxidase activity(GO:0004601) |
0.0 | 0.5 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.6 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 1.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.1 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.0 | 0.5 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.9 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 2.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.2 | GO:0098505 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) |
0.0 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 2.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.4 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 6.0 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.0 | 0.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 1.1 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 1.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 2.5 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.2 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.1 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 2.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 1.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 2.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 1.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 9.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.8 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 1.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 1.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.9 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 1.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 1.1 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 1.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.9 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 1.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.5 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 13.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 2.1 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.2 | 0.2 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.1 | 1.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 1.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 2.6 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 3.6 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 2.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 1.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 2.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 1.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 2.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 0.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 1.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.6 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 1.7 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.0 | 0.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 1.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.6 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 1.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 1.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.2 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.0 | 0.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.4 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 1.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.3 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 1.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |